Navigation Links
ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
Date:11/3/2009

ADDISON, Texas, Nov. 3 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) today announced that it has scheduled a conference call to discuss the third quarter ended September 30, 2009 financial results and provide a general business update on Tuesday, November 17, 2009 at 9:00 a.m. Eastern Time.

To participate in the conference call please dial (800) 357-0498, for international callers dial (850) 429-1388 (access code 23511#) five to ten minutes prior to the initiation of the teleconference. If you are unable to listen to the live broadcast, a replay of the call will be available starting on November 17, 2009 two hours following the end of the call until November 24, 2009 at 11:59 p.m. Eastern Time. For the U.S. replay, please dial (866) 415-9493 for international callers dial (585) 419-6446 (access code 23511#).

About ULURU Inc.:

ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers with improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex(TM) Aggregate technology and OraDisc(TM) transmucosal delivery system. For more information about ULURU Inc., please visit www.uluruinc.com. For more information about Altrazeal(TM), please visit www.Altrazeal.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2008 and other reports filed by us with the Securities and Exchange Commission.

    Contact: Company
    Renaat E. Van den Hooff
    President &a
'/>"/>
SOURCE ULURU Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
2. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
3. West Announces Third Quarter 2009 Results
4. Rigel Announces Third Quarter 2009 Financial Results
5. VIVUS Announces Promotion of Peter Tam to President
6. ATS Medical Announces Third Quarter 2009 Results
7. BioVex Announces Publication of Phase 2 Melanoma Results With OncoVEX (GM-CSF) in the Journal of Clinical Oncology
8. PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
9. Arcadia Resources Announces Webcast of Its Fiscal 2010 Second Quarter Conference Call
10. ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement
11. Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Cleveland Clinic President ... keynote address last month that industry is compelled to ... to gain the efficiencies—and develop the transformational innovations -- ... Barsoum,s comments were preceded by Doug Kohrs , ... OMTEC moderator, who stressed that industry must add "episode ...
(Date:7/30/2015)... FAIRFIELD, N.J. , July 30, 2015 /PRNewswire/ ... Ferrer, completed the second Phase III clinical study ... development for impetigo.  Medimetriks owns the exclusive U.S. ... The global trial, conducted at 44 centers with ... and pediatric patients aged 2 months and older ...
(Date:7/30/2015)... Calif. , July 30, 2015   ... to eliminate all preventable hospitalization, recently received confirmation ... its Remote Patient Intelligence (RPI) solution meets the ... FDA intends to exercise "Enforcement Discretion." ... not subject to further FDA regulatory requirements at ...
Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 2FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 3
(Date:7/30/2015)... ... July 30, 2015 , ... Dale Sky Jones, Executive Chancellor of ... the International Cannabis Professionals Expo held at the Caribe Royal All Suites Hotel and ... Professionals Expo is the largest medical cannabis expo in the country and this ...
(Date:7/30/2015)... ... 31, 2015 , ... The Venetian on Grace Bay in the Turks & Caicos Islands is ... Venetian will save 40% on their stay while enjoying some of the most beautiful ocean ... & Caicos, providing a chance to reconnect with loved ones and rediscover one's best self. ...
(Date:7/30/2015)... ... July 31, 2015 , ... Committed to helping the ... by asking community members to contribute to the College’s “My Brother’s Keeper Scholarship.” The ... young people stay on track. Providing the support they need to think more broadly ...
(Date:7/30/2015)... Sierra Madre, CA (PRWEB) , ... July 30, 2015 , ... ... wound care programs, the activity of recruiting patients becomes a serious challenge. Because of ... wound care program to patients within the local community. , The team at ...
(Date:7/30/2015)... ... July 30, 2015 , ... OSF Healthcare System has been ... Most Wired Survey conducted by Hospitals & Health Networks. This marks the fourth consecutive ... by The Sisters of the Third Order of St. Francis . , Health ...
Breaking Medicine News(10 mins):Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3
... Cytori Therapeutics (NASDAQ: CYTX) announced today the ... European Journal of Surgical Oncology. , ... trial using autologous adipose-derived regenerative cell (ADRC)-enriched fat ... surgery. The majority of patients underwent radiation prior ...
... sudden hearing loss, a frightening condition that sends thousands in ... this month in the journal OtolaryngologyHead and Neck Surgery ... led by Robert J. Stachler, M.D., an otolaryngologist in the ... in Detroit. "In most cases, patients will have ...
... , MONDAY, March 19 (HealthDay News) -- The emergency room ... blackouts can be more than half a million dollars a ... new study found. The University of Wisconsin-Madison ... the 28 days before the start of the study, male ...
... of Granada researchers have developed a software tool that ... person has to suffer a heart disease. In addition, ... estimations, i.e. it helps estimating the risk that a ... The researchers employed a sample including 3 000 patients. ...
... March 17 (HealthDay News) -- People who follow seven ... die than those who follow few or none of ... 45,000 U.S. adults. However, the researchers also found ... recommended by the American Heart Association (AHA), which include: ...
... 17 (HealthDay News) -- Teens and young adults who binge ... be risking brain damage, an expert warns. Binge drinking, ... drinks by males and three drinks by females in a ... said Dr. Alicia Ann Kowalchuk, medical director of the InSight ...
Cached Medicine News:Health News:Cytori breast reconstruction cell therapy trial results published 2Health News:First national guideline for sudden hearing loss published 2Health News:Excessive Drinking Costs U.S. Colleges Millions Annually 2Health News:Scientists develop a software tool for estimating heart disease risk 2Health News:Following Heart-Healthy Behaviors May Lengthen Your Life 2Health News:Following Heart-Healthy Behaviors May Lengthen Your Life 3Health News:Spring Break Boozing May Put Young Brains at Risk 2
Minimal M9CA Broth...
An agent used for making solid microbiological media....
... of miniTHERM incubators is available, ensuring the ... for their specific requirements. miniTHERM incubators have ... and extremely space saving. Their size corresponds ... is possible to stack up to three ...
In microbiological laboratories and for in vitro fertilization, as well as in cancer research or tissue engineering, the Heraeus CO2 incubator BBD 6220 provides the best contamination protection and ...
Medicine Products: